AIDS
J&J announces new partnerships in fight against HIV/AIDS
December 1, 2015Research and Development AIDS, HIV, Janssen
Johnson &Johnson is entering four new public-private partnerships aimed at significantly reducing the burden of HIV incidence among young girls …
Collaboration between MPP and University of Liverpool targets HIV nanomedicines
December 1, 2015Manufacturing and Production, Research and Development AIDS, HIV, Medicines Patent Pool, antiretrovirals, nanomedicines
The Medicines Patent Pool (MPP) and the University of Liverpool have agreed a partnership to use the university’s solid drug …
UN calls on pharma industry to make medicines more affordable
September 29, 2015Manufacturing and Production AIDS, HIV, Michel Sidibe, UNAIDS, United Nations, antiretroviral treatments
The United Nations AIDS agency, UNAIDS, has called on governments and the pharmaceutical industry to ensure that medicines remain accessible …
GSK launches new HIV research centre
May 11, 2015Research and Development, Sales and Marketing AIDS, GSK, HIV, UNC-Chapel Hill, ViiV, qura
GlaxoSmithKline is boosting its philanthropic efforts in R&D into HIV/AIDS by teaming up with academic researchers to launch a new …
GSK mulls $27 billion ViiV sell-off
October 23, 2014Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV
After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …
Twitter useful for tracking HIV outbreaks
March 5, 2014Medical Communications, Sales and Marketing AIDS, HIV, Twitter, digital, flu, ucla, virus, wells
A study by UCLA researchers has shown that Twitter and social media can be used as a practical real-time tool …
Janssen eases HIV patent burden
December 3, 2012Sales and Marketing AIDS, Janssen, Prezista, darunavir
In a move which should appeal to public health campaigners, Janssen has declared that it will not enforce patents for …
Gates urges investment in innovations for developing nations
January 25, 2012Research and Development AIDS, Bill Gates, Global Fund, TB, malaria
Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …
Gilead’s pill shows promise in HIV prevention
November 25, 2010Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir
Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …
UN says Treatment 2.0 approach needed for AIDS
November 25, 2010Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS
A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
